Major Pharmaceutical Risk Management Seminar Slated for November

Busy pharmaceutical industry professionals need the latest information to be competitive. This one day seminar will touch on vital industry developments in the global pharmaceutical marketplace.

Major Pharmaceutical Risk Management Seminar Slated for November

Huntingdon Valley, PA June 27, 2002----Pharmaceutical executives, trademark attorneys, product managers, and regulatory affairs specialists take note. Friday, November 1, 2002 Med-E.R.R.S. Inc. (Medical Error Recognition and Revision Strategies, Inc.) is sponsoring a one-day educational seminar covering the latest developments in the field of medication safety as they relate to pharmaceutical products.
Minimizing Pharmaceutical Trademark, Packaging and Labeling Risks" features leaders from the fields of medication safety, trademark development, labeling, packaging, international developments, and regulatory affairs. Individual sessions will cover:
> Whats Happening in Medication Safety
> Errors relating to Labeling,Packaging, and Nomenclature
> FDA Update-Restructuring, Post Market Surveillance, and Advertising
> International Perspective on Error Prevention
> Integrating Safety in Trademark Development Process: The Trademark Attorney as Risk Manager
> Using Failure Mode and Effects Analysis (FMEA) to prevent errors with trademarks, packaging, and labeling: The Med-E.R.R.S. process
> Trademark Troubleshooting: Putting Out Fires at the FDA
This seminar is tailored to meet the needs of all pharmaceutical companies regardless of their level of internal resources and expertise. Staying on the cutting edge of developments in the competitive global pharmaceutical market is a must if companies want to remain successful. According to Susan Proulx, Pharm.D., President of Med-E.R.R.S., We believe the Med-E.R.R.S. FMEA process has helped set the industry standard for preventing medication errors related to trademarks, packaging and labeling."
After completing the seminar, participants will be able to:
> Identify the safety risks relating to naming, labeling, and packaging of pharmaceutical products
> Recognize and understand the recent changes in the regulatory environment both in the US and internationally
> Streamline the trademark process within their company
> Recognize the role of failure mode and effects analysis (FMEA) in developing safe trademarks, drug packaging, and labeling
> Understand the specific role of industry professionals in reducing medication errors
> Establish risk management approaches to safety concerns raised by regulatory authorities

Registration is limited, so be among the first to reserve a place at this seminar. Make plans now to join Med-E.R.R.S. Friday, November 1, 2002 at the Conference Center of the New Jersey Hospital Association in Princeton, NJ. For more information, contact Med-E.R.R.S., Inc., at 215-947-8306, e-mail info@med-errs.com or visit our website www.med-errs.com.